Works by Yoshino, Takayuki
Results: 211
Novel Immunological Approaches in the Treatment of Locally Advanced Rectal Cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prognostic Value and Molecular Landscape of HER2 Low-Expressing Metastatic Colorectal Cancer.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic and Predictive Value of HER2 Amplification in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rationale for and Design of the PARADIGM Study: Randomized Phase III Study of mFOLFOX6 Plus Bevacizumab or Panitumumab in Chemotherapy-naïve Patients With RAS (KRAS/NRAS) Wild-type, Metastatic Colorectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Rationale and Design for the LUME-Colon 1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Nintedanib Plus Best Supportive Care Versus Placebo Plus Best Supportive Care in Patients With Advanced Colorectal Cancer Refractory to Standard Treatment.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Concordance between PIK3CA mutations in endoscopic biopsy and surgically resected specimens of esophageal squamous cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgery.
- Published in:
- Journal of Surgical Oncology, 2016, v. 113, n. 4, p. 390, doi. 10.1002/jso.24151
- By:
- Publication type:
- Article
Possible risk of overestimation of renal function using cystatin C-based eGFR in testicular cancer survivors treated with cisplatin-based chemotherapy.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 3, p. 727, doi. 10.1007/s10157-017-1474-x
- By:
- Publication type:
- Article
Tumor specimen cold ischemia time impacts molecular cancer drug target discovery.
- Published in:
- Cell Death & Disease, 2024, v. 15, n. 9, p. 1, doi. 10.1038/s41419-024-07090-x
- By:
- Publication type:
- Article
TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer.
- Published in:
- PLoS ONE, 2019, v. 14, n. 8, p. 1, doi. 10.1371/journal.pone.0220173
- By:
- Publication type:
- Article
A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study.
- Published in:
- Langenbeck's Archives of Surgery, 2022, v. 407, n. 4, p. 1345, doi. 10.1007/s00423-022-02434-7
- By:
- Publication type:
- Article
Histopathological factors affecting the extraction of high quality genomic DNA from tissue sections for next-generation sequencing.
- Published in:
- Biomedical Reports, 2019, v. 11, n. 4, p. 171, doi. 10.3892/br.2019.1235
- By:
- Publication type:
- Article
Fecal microbiota in patients with a stoma decreases anaerobic bacteria and alters taxonomic and functional diversities.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 01, doi. 10.3389/fcimb.2022.925444
- By:
- Publication type:
- Article
Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-53223-3
- By:
- Publication type:
- Article
Post-marketing surveillance study of trifluridine/tipiracil in patients with metastatic colorectal cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 700, doi. 10.1093/jjco/hyaa243
- By:
- Publication type:
- Article
Clinical impact of renal impairment on the safety and efficacy of S-1 plus oxaliplatin in patients with advanced gastric cancer: a single institutional study.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 2, p. 129, doi. 10.1093/jjco/hyz157
- By:
- Publication type:
- Article
Clinical impact of baseline renal function on safety and early discontinuation of adjuvant capecitabine plus oxaliplatin in elderly patients with resected colon cancer: a multicenter post-marketing surveillance study.
- Published in:
- Japanese Journal of Clinical Oncology, 2020, v. 50, n. 2, p. 122, doi. 10.1093/jjco/hyz149
- By:
- Publication type:
- Article
Laparoendoscopic single‐site surgery for urachal remnant with extraperitoneal approach through a suprapubic port.
- Published in:
- Asian Journal of Endoscopic Surgery, 2022, v. 15, n. 3, p. 569, doi. 10.1111/ases.13056
- By:
- Publication type:
- Article
Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920942377
- By:
- Publication type:
- Article
Correction: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to `Comment on `Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study''.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 7, p. 7808, doi. 10.1002/cam4.5541
- By:
- Publication type:
- Article
BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 6998, doi. 10.1002/cam4.4227
- By:
- Publication type:
- Article
p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40612-9
- By:
- Publication type:
- Article
p70S6K/Akt dual inhibitor DIACC3010 is efficacious in preclinical models of gastric cancer alone and in combination with trastuzumab.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-40612-9
- By:
- Publication type:
- Article
Risk analyses of nocturia on incident poor sleep and vice versa: the Nagahama study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36707-y
- By:
- Publication type:
- Article
Case Report: A Case of Renal Cell Carcinoma Unclassified With Medullary Phenotype Exhibiting a Favorable Response to Combined Immune Checkpoint Blockade.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.934991
- By:
- Publication type:
- Article
Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer.
- Published in:
- Case Reports in Oncological Medicine, 2020, p. 1, doi. 10.1155/2020/7231358
- By:
- Publication type:
- Article
Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study.
- Published in:
- Current Medical Research & Opinion, 2021, v. 37, n. 10, p. 1769, doi. 10.1080/03007995.2021.1940908
- By:
- Publication type:
- Article
5-Fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer: a randomized Phase IIb study.
- Published in:
- Cancer Management & Research, 2015, v. 7, p. 165, doi. 10.2147/CMAR.S61408
- By:
- Publication type:
- Article
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prediction of undetectable circulating tumor DNA by comprehensive genomic profiling assay in metastatic prostate cancer: the SCRUM-Japan MONSTAR SCREEN project.
- Published in:
- World Journal of Urology, 2024, v. 42, n. 1, p. 1, doi. 10.1007/s00345-024-05240-6
- By:
- Publication type:
- Article
Clinicopathological Study of Early Adenocarcinoma of the Gastric Cardia: Comparison with Early Adenocarcinoma of the Distal Stomach and Esophagus.
- Published in:
- Oncology, 2001, v. 61, n. 1, p. 1, doi. 10.1159/000055345
- By:
- Publication type:
- Article
Solitary recurrence of prostate cancer surrounded by seminal vesicle/vas deferens‐like epithelium.
- Published in:
- IJU Case Reports, 2020, v. 3, n. 5, p. 171, doi. 10.1002/iju5.12168
- By:
- Publication type:
- Article
The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine.
- Published in:
- Pathology International, 2021, v. 71, n. 11, p. 725, doi. 10.1111/pin.13170
- By:
- Publication type:
- Article
Impact of DNA integrity on the success rate of tissue‐based next‐generation sequencing: Lessons from nationwide cancer genome screening project SCRUM‐Japan GI‐SCREEN.
- Published in:
- Pathology International, 2020, v. 70, n. 12, p. 932, doi. 10.1111/pin.13029
- By:
- Publication type:
- Article
Nivolumab Plus Ipilimumab vs Chemotherapy as First-Line Treatment for Microsatellite Instability-High/Mismatch Repair--Deficient Metastatic Colorectal Cancer: Expanded Efficacy Analysis From Checkmate 8HW.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2024, v. 15, n. 10, p. 313
- By:
- Publication type:
- Article
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 100, doi. 10.1016/j.clcc.2022.11.002
- By:
- Publication type:
- Article
Molecular Residual Disease-guided Adjuvant Treatment in Resected Colorectal Cancer: Focus on CIRCULATE-Japan.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 53, doi. 10.1016/j.clcc.2022.12.001
- By:
- Publication type:
- Article
Trajectory for the Regulatory Approval of a Combination of Pertuzumab Plus Trastuzumab for Pre-treated HER2-positive Metastatic Colorectal Cancer Using Real-world Data.
- Published in:
- 2023
- By:
- Publication type:
- journal article
Health-related Quality of Life in the Phase III LUME-Colon 1 Study: Comparison and Interpretation of Results From EORTC QLQ-C30 Analyses.
- Published in:
- 2019
- By:
- Publication type:
- journal article